Doctors Pathology Services, PA

Doctors Pathology Services, PA was paid $1.03M by Medicaid between Jan 2018 and Nov 2024, across 26 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 45% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	4,935	$16K
2019	6,646	$45K
2020	5,212	$178K
2021	13,300	$441K
2022	7,754	$255K
2023	3,429	$83K
2024incomplete	1,204	$16K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	45%	5,517	4,534	$465K
88305	Level IV - Surgical pathology, gross and microscopic examination	16%	4,407	3,118	$164K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	8.9%	4,777	3,873	$92K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	5.5%	3,835	3,194	$57K
88342		3.6%	1,165	793	$37K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	3.2%	3,836	3,194	$34K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	3.1%	3,268	2,656	$32K
87481		2.8%	2,427	1,248	$29K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	2.6%	1,856	1,739	$26K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.8%	1,456	1,344	$18K
81513		1.7%	211	191	$17K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	1.7%	1,217	1,039	$17K

14 more codes

88304		1.4%	844	$14K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	757	$7K
99001		<1%	5,505	$7K
87511		<1%	753	$7K
88312		<1%	122	$5K
88341		<1%	68	$2K
87653		<1%	109	$2K
G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	<1%	159	$919.71
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	13	$502.80
G0141	Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician	<1%	84	$473.00
88313		<1%	14	$412.50
88141		<1%	51	$92.96
87081		<1%	15	$42.34
99000		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSUKUMAR, RAY (MEDICAL DIRECTOR)